Reply

Hepatology

Volumn 62, Issue 5, 2015, Pages 1643-

  Pineda Tenor, Daniel ^a   García Álvarez, Mónica ^a   Jiménez Sousa, María A ^a   Fernández Rodríguez, Amanda ^a   Resino, Salvador ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PEGINTERFERON ALPHA; RIBAVIRIN; ANTIVIRUS AGENT; VITAMIN D;

CLINICAL PRACTICE; HUMAN; LETTER; MICROBIOLOGICAL PARAMETERS; PRIORITY JOURNAL; SUSTAINED VIROLOGIC RESPONSE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; BLOOD; CHRONIC HEPATITIS C; COMPLICATION; LIVER CIRRHOSIS;

ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; VITAMIN D;

EID: 84945451075     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27796     Document Type: Letter

References (5)

1. García-Álvarez M, Pineda-Tenor D, Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, Resino S. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis. Hepatology 2014;60:1541-1550.
2. Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011;53:1118-1126.
3. Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, et al. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012;56:1641-1650.
4. Bitetto D, Bortolotti N, Falleti E, Vescovo S, Fabris C, Fattovich G, et al. Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy. Hepatology 2013;57:925-933.
5. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011;24:43-50.